Exelon Co. (NYSE:EXC) Holdings Boosted by Pacer Advisors Inc.

Share on StockTwits

Pacer Advisors Inc. boosted its holdings in Exelon Co. (NYSE:EXC) by 10.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 102,664 shares of the energy giant’s stock after acquiring an additional 9,810 shares during the period. Pacer Advisors Inc.’s holdings in Exelon were worth $4,960,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of EXC. Kempen Capital Management N.V. bought a new position in Exelon in the second quarter worth about $27,000. Quantamental Technologies LLC bought a new position in Exelon in the second quarter worth about $29,000. Manchester Financial Inc. bought a new position in Exelon in the second quarter worth about $30,000. Resources Investment Advisors LLC. raised its holdings in shares of Exelon by 167.5% during the second quarter. Resources Investment Advisors LLC. now owns 634 shares of the energy giant’s stock valued at $30,000 after buying an additional 397 shares during the last quarter. Finally, Weaver Consulting Group bought a new stake in shares of Exelon during the first quarter valued at approximately $31,000. 78.99% of the stock is currently owned by hedge funds and other institutional investors.

EXC opened at $47.51 on Friday. The business’s 50 day moving average is $47.65 and its 200-day moving average is $48.34. The stock has a market cap of $46.16 billion, a PE ratio of 15.23, a price-to-earnings-growth ratio of 4.50 and a beta of 0.26. The company has a current ratio of 0.90, a quick ratio of 0.77 and a debt-to-equity ratio of 0.95. Exelon Co. has a twelve month low of $42.44 and a twelve month high of $51.18.

Exelon (NYSE:EXC) last posted its quarterly earnings data on Thursday, August 1st. The energy giant reported $0.60 EPS for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.03). Exelon had a net margin of 6.43% and a return on equity of 8.47%. The company had revenue of $7.69 billion for the quarter, compared to analyst estimates of $7.03 billion. During the same quarter in the prior year, the business earned $0.71 EPS. Exelon’s revenue was down 4.8% compared to the same quarter last year. As a group, analysts forecast that Exelon Co. will post 3.14 EPS for the current year.

A number of equities research analysts have recently weighed in on EXC shares. SunTrust Banks set a $49.00 price target on Exelon and gave the company a “hold” rating in a report on Tuesday, September 3rd. ValuEngine cut Exelon from a “buy” rating to a “hold” rating in a report on Tuesday, July 23rd. Argus reaffirmed a “buy” rating and set a $53.00 price target on shares of Exelon in a report on Wednesday, September 18th. UBS Group lifted their price target on Exelon from $53.00 to $55.00 and gave the company a “buy” rating in a report on Friday, September 6th. Finally, Barclays reaffirmed a “buy” rating and set a $54.00 price target on shares of Exelon in a report on Thursday, September 26th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $52.29.

Exelon Profile

Exelon Corporation, a utility services holding company, engages in energy generation and delivery businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.

Featured Article: Ex-Dividend

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NYSE:EXC).

Institutional Ownership by Quarter for Exelon (NYSE:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.